Dr. Joseph de Beauchamp of World Financial News Network gives favorable analysis of VitalSat. They develop patient monitoring equipment with the end-user in mind and to maintain and enhance their reputation for customer service and support. VitalSAT plans to grow as certified medical device company. When the Company was formed, VBI's mission was to identify new medical device technologies it could introduce to the global marketplace.
Seattle, WA (PRWEB) September 6, 2004 -- WFNN's consistently outperforms established industry benchmark indicators. Based on in-depth research and analysis, their analysts recommend securities worldwide showing the highest probability for stock price appreciation.
Dr. Joseph de Beauchamp, WFNN's Chief Independent Analyst, said, "VitalStat is starting out without pre-conceived notions of marketing and capital raise. Therefore we see this company hitting about thirty million in sales in the next three years. With this sales volume, the company would reach ten cents per share earnings in the next three years. This would push the share price up to around $5.00 per share on ten million shares outstanding."
For brief information of this new, dynamic company, examine: http://wfnn.info displaying on the front page.
About WFNN
World Financial News Network provides a unique blend of data, timely information and today's technologies to assist with up-to-the-minute investment information on markets and investments around the world.
About VitalSat
VitalSat is dedicated to developing state of the art patient monitoring equipment with the end-user in mind and to maintain and enhance their reputation for customer service and support. VitalSat is a dynamic and rapidly growing certified medical device company. When the Company was formed, VBI's mission was to identify new medical device technologies it could introduce to the global marketplace.
Wayne Webber, CFO
VitalSAT Biomedical Inc
24A Garfield Street
Charlottetown, PEI
Canada
902-892-2932
http://www.vital-sat.com
wwebber@vital-stat.com
# # #
|
